Under pathological conditions, such as tumour growth, GRP94 is dramatically up-regulated as a survival mechanism [30], being its overexpression associated with a more aggressive tumour phenotype and a poor evolution of the disease [31,32]. Here, HSP90B1 is linked to neoplasm.